The SHIELD Whole Lung Lavage Study

NCT05402176 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-06-02

No results posted yet for this study

Summary

An observational cohort study that will assess the efficacy of Whole Lung Lavage in workers with silicosis or silica-induced bronchitis.

Conditions

  • Silicosis

Interventions

OTHER

Whole Lung Lavage

Whole Lung Lavage (WLL) is performed as standard of care. Outcome following WLL is observed.

Sponsors & Collaborators

  • The University of Queensland

    lead OTHER

Principal Investigators

  • Daniel Chambers · The Prince Charles Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-30
Primary Completion
2024-06-30
Completion
2024-12-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05402176 on ClinicalTrials.gov